• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ACCRIVA DIAGNOSTICS HEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM; SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ACCRIVA DIAGNOSTICS HEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM; SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES Back to Search Results
Model Number ELITEINT
Device Problem Low Test Results (2458)
Patient Problem Missing Value Reason (3192)
Event Date 03/26/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Actual device not evaluated.Process evaluation performed.No ncs, irs capas or instrument repairs recorded in the dhr.No results available since no evaluation performed.Device not returned.Accriva diagnostics has requested all data required for form 3500a.An instrument evaluation is anticipated.Results of the evaluation will be submitted as mdr 2250033-2018-00010 follow-up #1.
 
Event Description
Distributor of accriva products for (b)(4) reported a lower than expected act result with a hemochron signature elite and act+ microcoagulation system.During an unspecified procedure in the cath lab, the patient reportedly received an unspecified bolus dose of heparin with a target act of 300 seconds.The patient's initials, age, gender and weight were not specified.The type of procedure, act draw time(s) and results, concomitant medications and clinical circumstances of the case are unknown at the time of this report; however, this information has been requested.
 
Event Description
Follow-up #1.
 
Manufacturer Narrative
Mdr 2250033-2018-00010 follow-up #1 provides the results of the instrument evaluation for the hemochron signature elite instrument, serial number (b)(4) named in accriva diagnostics' complaint number (b)(4).This follow-up mdr also provides the date of manufacture on this instrument.Additional information to device mfr date: 10/12/2016.Method code: 10: testing of actual/suspected device.Results code: 213: no device problem found.Donor whole blood was assayed and results were found to be within specification.Electronic qc passed as well.Conclusion code: 67: no problem detected.This follow-up mdr documents closure of this complaint.No additional reports are required.
 
Event Description
Follow-up #2.
 
Manufacturer Narrative
D4: catalog number: eliteint.Model number: eliteint.Udi: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM
Type of Device
SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES
Manufacturer (Section D)
ACCRIVA DIAGNOSTICS
6260 sequence drive
san diego CA 92121
MDR Report Key7470847
MDR Text Key106873485
Report Number2250033-2018-00010
Device Sequence Number1
Product Code JPA
UDI-Device Identifier10711234510018
UDI-Public0110711234510018
Combination Product (y/n)N
PMA/PMN Number
K050016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Type of Report Initial,Followup,Followup
Report Date 09/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/27/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Model NumberELITEINT
Device Catalogue NumberELITEINT
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/24/2018
Was the Report Sent to FDA? No
Date Manufacturer Received09/19/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-